Abiopharma

🔍 Wheeler David Leigh (Executive)

Company: Firefly Aerospace Inc. (FLY)

Report Date: 2026-04-17

Detailed Transactions and Holdings:

• Acquired 3,766 shares of Common Stock at $2.3106 per share (Direct)
  Date: 2026-04-17 | Code: M | equity_swap_involved: false | shares_owned_after: 146,524.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,766 shares of Common Stock at $45.0366 per share (Direct)
  Date: 2026-04-17 | Code: S | equity_swap_involved: false | shares_owned_after: 142,758.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 3,766 shares of Employee Stock Option (right to buy) at $2.3106 per share (Derivative)
  Date: 2026-04-17 | Code: M | Expires: 2035-05-05 | equity_swap_involved: false | shares_owned_after: 299,757.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 5, 2025.
• F2: Represents a weighted average sale price with individual transaction prices ranging from $45.00 to $45.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: A portion of these securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• F4: All of the shares subject to the option are fully vested and exercisable as of the date hereof.